- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Unresectable Renal Cell Carcinoma
Total 13000 results
-
AstraZenecaRecruitingUnresectable /Inoperable Locally Advanced (Stage II-III) Non-small Cells Lung Cancer (NSCLC)Russian Federation
-
BeiGeneActive, not recruitingResectable Esophageal Squamous Cell CarcinomaChina
-
UroGen Pharma Ltd.RecruitingCarcinoma, Transitional Cell | Urothelial Carcinoma | Urothelial Cancer of Renal Pelvis | Urothelial Carcinoma Ureter | Urothelial Carcinoma Recurrent | Urothelial Carcinoma of the Renal Pelvis and Ureter | Urothelial Carcinoma Ureter Recurrent | Transitional Cell Carcinoma of Renal PelvisUnited States
-
CStone PharmaceuticalsActive, not recruitingUnresectable Locally Advanced, Recurrent or Metastatic Esophageal Squamous Cell CarcinomaChina
-
University of California, San FranciscoProstate Cancer Foundation; Strata OncologyActive, not recruitingProstate Cancer | Advanced Renal Cell Carcinoma | Genitourinary Cancer | Advanced Urothelial CarcinomaUnited States
-
National Cancer Institute (NCI)CompletedAdvanced Adult Hepatocellular Carcinoma | Localized Non-Resectable Adult Liver Carcinoma | Recurrent Adult Liver Carcinoma | Recurrent Gallbladder Carcinoma | Stage IV Distal Bile Duct Cancer | Stage IV Gallbladder Cancer | Unresectable Extrahepatic Bile Duct Carcinoma | Unresectable Gallbladder...United States
-
Jiangsu HengRui Medicine Co., Ltd.Cancer Institute and Hospital, Chinese Academy of Medical SciencesCompletedMetastatic Renal Cell Cancer | Renal Cell CancerChina
-
Yonsei UniversityRecruitingClear Renal Cell Cancer (< 7cm Size)Korea, Republic of
-
National Cancer Institute (NCI)CompletedKidney CancerUnited States
-
HiberCell, Inc.CovanceTerminatedA Study of HC-7366 to Establish the Maximum Tolerated Dose (MTD) and Recommended Phase 2 Dose (RP2D)Clear Cell Renal Cell Carcinoma | Non Small Cell Lung Cancer | Squamous Cell Carcinoma of Head and Neck | Colo-rectal Cancer | Transitional Cell Carcinoma of the Bladder | Other Solid TumorsUnited States
-
Seoul National University HospitalPfizerCompletedRenal Cell Carcinoma | Nonclear Cell | Temsirolimus ResistanceKorea, Republic of
-
Rambam Health Care CampusRoche Pharma AGUnknown
-
Wake Forest University Health SciencesRecruitingNonsmall Cell Lung Cancer Stage III | Unresectable Non-Small Cell Lung CarcinomaUnited States
-
Wenxin XuRecruitingKidney Cancer | Renal Cell Carcinoma | Metastatic Renal Cell CarcinomaUnited States
-
Abramson Cancer Center at Penn MedicineTerminatedRenal Cell Carcinoma | Renal Cell Carcinoma Stage IVUnited States
-
Incyte CorporationMerck Sharp & Dohme LLCActive, not recruitingRenal Cell Carcinoma (RCC)Canada, France, United States, Spain, United Kingdom, Italy, Taiwan, Australia, Norway, Korea, Republic of, Germany, Russian Federation, Japan, Brazil, Turkey, Ukraine, Hungary, New Zealand, Chile, Ireland
-
H. Lee Moffitt Cancer Center and Research InstitutePfizerActive, not recruitingRenal Cell Carcinoma Stage IVUnited States
-
Jiangsu Hansoh Pharmaceutical Co., Ltd.Not yet recruitingRenal Cell Carcinoma
-
Peloton Therapeutics, Inc., a subsidiary of Merck...Active, not recruitingKidney Cancer | Renal Cell Carcinoma | Clear Cell Renal Cell Carcinoma | ccRCC | RCCUnited States
-
Merck Sharp & Dohme LLCEisai Inc.Active, not recruitingCarcinoma, Renal CellUnited States, Colombia, Canada, Australia, Finland, Japan, United Kingdom, Brazil, Chile, China, Croatia, Czechia, Denmark, France, Germany, Guatemala, Hungary, Ireland, Italy, Korea, Republic of, Malaysia, Mexico, Norway, Philippines, Polan... and more
-
Aravive, Inc.TerminatedClear Cell Renal Cell CarcinomaUnited States
-
Mayo ClinicNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol Specific | Recurrent Melanoma | Stage IV Melanoma | Gastrinoma | Glucagonoma | Insulinoma | Metastatic Gastrointestinal Carcinoid Tumor | Pancreatic Polypeptide Tumor | Recurrent Gastrointestinal Carcinoid Tumor | Recurrent Islet Cell Carcinoma | Somatostatinoma | Stage... and other conditionsUnited States
-
Hyunseok Kang, MDNeoImmuneTechRecruitingRecurrent Head and Neck Squamous Cell Carcinoma | Recurrent Hypopharyngeal Squamous Cell Carcinoma | Recurrent Laryngeal Squamous Cell Carcinoma | Recurrent Oral Cavity Squamous Cell Carcinoma | Recurrent Oropharyngeal Squamous Cell Carcinoma | Resectable Oropharyngeal Squamous Cell CarcinomaUnited States
-
National Cancer Institute (NCI)RecruitingMetastatic Merkel Cell Carcinoma | Refractory Merkel Cell Carcinoma | Locally Advanced Merkel Cell Carcinoma | Unresectable Merkel Cell Carcinoma | Clinical Stage III Cutaneous Merkel Cell Carcinoma AJCC v8 | Clinical Stage IV Cutaneous Merkel Cell Carcinoma AJCC v8United States
-
PROspective Renal Cancer Cohort FoundationBristol-Myers Squibb; Merck Sharp & Dohme LLC; Ipsen; Comprehensive Cancer Centre...RecruitingRenal Cell Carcinoma | Renal Cancer | Renal Cell Cancer MetastaticNetherlands
-
TScan Therapeutics, Inc.Washington University School of MedicineWithdrawnRenal Clear Cell CarcinomaUnited States
-
Gregory DanielsRecruitingMelanoma Stage Iv | Renal Cell Carcinoma, MetastaticUnited States
-
Merck Sharp & Dohme LLCActive, not recruitingCarcinoma, Renal CellUnited States
-
Indiana UniversityActive, not recruitingMelanoma; Renal Cell CarcinomaUnited States
-
Seoul National University HospitalTerminatedMetastatic Malignant Melanoma and Renal Cell CarcinomaKorea, Republic of
-
Novartis PharmaceuticalsCompletedAdvanced/ Metastatic Renal Cell CancerFrance, Spain, Germany, Taiwan, Netherlands, United States
-
Zhigang LiJiangsu HengRui Medicine Co., Ltd.Not yet recruitingLocally Advanced Resectable Esophageal Squamous Cell CarcinomaChina
-
Zhejiang Cancer HospitalUnknownEsophageal Squamous Cell Carcinoma ResectableChina
-
M.D. Anderson Cancer CenterRecruitingRenal Medullary Carcinoma | CarcinomasUnited States
-
Radboud University Medical CenterNovo Nordisk A/SCompletedRenal Cell CancerNetherlands
-
Osel, Inc.City of Hope Comprehensive Cancer Center; Miyarisan Pharmaceutical Co., Ltd.RecruitingAdvanced or Metastatic Renal Cell CarcinomaUnited States
-
john eisenbreyNational Cancer Institute (NCI)RecruitingRenal Cell Carcinoma | Recurrent Renal Cell CarcinomaUnited States
-
IpsenRecruitingAdvanced or Metastatic Renal Cell CarcinomaBelgium
-
National Cancer Institute, NaplesRecruitingMetastatic Renal Cell Carcinoma | RCCItaly
-
Stanford UniversityNational Institutes of Health (NIH)Active, not recruitingKidney Cancer | Renal Cell Carcinoma | Metastatic Renal Cell CarcinomaUnited States
-
Radboud University Medical CenterCompletedMetastatic Renal Cell Cancer | GISTNetherlands
-
Sunnybrook Health Sciences CentreMerck Sharp & Dohme LLC; Ozmosis Research Inc.CompletedStage IV Renal Cell Cancer AJCC V7Canada
-
University of Southern CaliforniaNational Cancer Institute (NCI)TerminatedRecurrent Renal Cell CancerUnited States
-
University of Texas Southwestern Medical CenterRecruitingRenal Cell Carcinoma | Renal Tumor | Renal Tumor, BenignUnited States
-
Abramson Cancer Center at Penn MedicineMerck Sharp & Dohme LLCRecruitingRenal Cell CarcinomaUnited States
-
Zhejiang Cancer HospitalRecruiting
-
Affiliated Hospital of Jiangnan UniversityRecruiting
-
University Hospital, LilleRecruitingRenal Cell CarcinomaFrance
-
Assiut UniversityNot yet recruitingRenal Cell Carcinoma
-
Radboud University Medical CenterRecruiting